Exchange: NASDAQ·Updated 07:43 PM EST

OABI News

News
all
press releases
OmniAb (NASDAQ:OABI) Stock Price Breaks Below 50 Day Moving Average - Here's What Happened
OmniAb (NASDAQ:OABI) Stock Crosses Below Fifty Day Moving Average - Here's What Happened...
MarketBeat
OmniAb (NASDAQ:OABI) Stock Price Breaks Below 50 Day Moving Average - Here's What Happened
OmniAb (NASDAQ:OABI) Stock Crosses Below Fifty Day Moving Average - Here's What Happened...
MarketBeat
More News
OmniAb (NASDAQ:OABI) reported third-quarter financial results on Friday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...
Benzinga
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
OmniAb, Inc. (OABI) delivered earnings and revenue surprises of 0.00% and +10.12%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today reported financial results for the three and nine months ended September 30, 2026, provided operating and partner program progress, and updated 2026...
Business Wire
OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced managements participation in the following upcoming investor conferences: Stifel Healthcare Conference Date: Wednesday, November 11, 2026...
Business Wire
OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced the Company will report financial results for the three and nine months ended September 30, 2026, before the open of the U.S. financial...
Business Wire
OmniAb, Inc. (OABI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today hosts its Investor & Analyst Day in Emeryville, CA. With a full presentation agenda, the event highlights recent partner developments, the broader...
Business Wire
OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today reiterates details of its upcoming Investor & Analyst Day, to be held on October 6, 2026, in Emeryville, CA. The event will feature presentations from...
Business Wire

Advertisement|Remove ads.